These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9186708)

  • 1. Anti-p53 autoantibodies in colon cancer patients.
    Sthoeger Z; Evron E; Goland S; Shani A; Wolkowicz R; Goldfinger N; Rotter V; Fogel M
    Ann N Y Acad Sci; 1997 Apr; 815():496-8. PubMed ID: 9186708
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the soluble p53 antigen and its autoantibodies as markers for diagnosis of colon cancer: a comparative study.
    Sandler B; Smirnoff P; Shani A; Idelevich E; Pfefferman R; Davidovich B; Zusman R; Zusman I
    Int J Mol Med; 1998 Feb; 1(2):453-7. PubMed ID: 9852249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against p53 are not increased in human ascites and pleural effusions.
    Munker R; Stötzer O; Darsow M; Classen S; Lebeau A; Wilmanns W
    Cancer Immunol Immunother; 1996 Mar; 42(3):200-1. PubMed ID: 8640849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer.
    Agaylan A; Binder D; Sauer M; Neuweiler H; Meyer O; Kiesewetter H; Salama A
    Cancer; 2007 Dec; 110(11):2502-6. PubMed ID: 17932907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-p53 antibodies in serum of smokers and head and neck cancer patients.
    Wollenberg B; Jan NV; Pitzke P; Reiter W; Stieber P
    Anticancer Res; 1997; 17(1A):413-8. PubMed ID: 9066686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to p53 in sera of patients with autoimmune thyroid disease.
    Fenton CL; Patel A; Tuttle RM; Francis GL
    Ann Clin Lab Sci; 2000 Apr; 30(2):179-83. PubMed ID: 10807162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the diagnostic accuracy of three commercially available enzyme immunoassays for anti-p53 antibodies.
    Rohayem J; Conrad K; Zimmermann T; Frank KH
    Clin Chem; 1999 Nov; 45(11):2014-6. PubMed ID: 10545076
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of anti-p53-autoantibodies in pancreatic disorders.
    Gansauge S; Gansauge F; Negri G; Galle P; Müller J; Nüssler AK; Poch B; Beger HG
    Int J Pancreatol; 1996 Jun; 19(3):171-8. PubMed ID: 8807362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of autoantibodies against p53 in Taiwanese lung cancer patients undergoing chemotherapy.
    Lee YL; Shih CM; Chiou HL; Shiau MY; Chang GC; Chang YH
    Clin Chim Acta; 2004 Nov; 349(1-2):87-96. PubMed ID: 15469860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer.
    Marx D; Frey M; Zentgraf H; Adelssen G; Schauer A; Kuhn W; Meden H
    Cancer Detect Prev; 2001; 25(2):117-22. PubMed ID: 11341346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of serum anti-p53 antibody measurement for colorectal cancer].
    Kuwabara K; Kumamoto K; Ishibashi K; Ohsawa T; Kumagai Y; Baba H; Tsuji Y; Haga N; Ishida H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2167-9. PubMed ID: 23268012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N- or C-terminus of p53.
    Saleh J; Kreissler-Haag D; Montenarh M
    Int J Oncol; 2004 Oct; 25(4):1149-55. PubMed ID: 15375567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of apoptosis, proliferating cell nuclear antigen and p53 protein in the immune response of rat colon cells to cancer and vaccination with anti-p53 polyclonal antibodies.
    Tendler Y; Ben-Hur H; Gurevich P; Berman V; Sandler B; Nyska A; Zion H; Zinder O; Zusman I
    Anticancer Res; 1997; 17(6D):4653-7. PubMed ID: 9494584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 autoantibodies from patients with head and neck cancer recognise common epitopes on the polypeptide chain of p53.
    Saleh J; Brunner C; Gölzer R; Nastainczyk W; Montenarh M
    Cancer Lett; 2006 Feb; 233(1):48-56. PubMed ID: 15913883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast.
    Regele S; Kohlberger P; Vogl FD; Böhm W; Kreienberg R; Runnebaum IB
    Br J Cancer; 1999 Oct; 81(4):702-4. PubMed ID: 10574259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.
    Vogl FD; Frey M; Kreienberg R; Runnebaum IB
    Br J Cancer; 2000 Nov; 83(10):1338-43. PubMed ID: 11044359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
    Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F
    Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-p53 antibodies in patients with lung cancer.
    Mack U; Ukena D; Montenarh M; Sybrecht GW
    Oncol Rep; 2000; 7(3):669-74. PubMed ID: 10767388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between serum p53 autoantibodies and characteristics of human breast cancer.
    Mudenda B; Green JA; Green B; Jenkins JR; Robertson L; Tarunina M; Leinster SJ
    Br J Cancer; 1994 Jun; 69(6):1115-9. PubMed ID: 8198980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.